Nicole L. Tegg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nicole L. Tegg has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Colleen M. Norris
University of Alberta
7 shared publications Colleen M. Norris
5 shared publicationsJenna Semmens
3 shared publicationsCaitlynd Myburgh
Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada
2 shared publications- Caitlynd Myburgh
Hypertension in Africa Research Team (HART), North-West University, Private Bag X6001, Potchefstroom, 2520, South Africa
2 shared publications - Megan Kennedy
University of Alberta
2 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e046951
Sex‐Specific Gaps in Cardiovascular Psychosocial Research: An Analysis of Studies Cited in the American Heart Association's 2021 Statement on Psychological Health and Cardiovascular Disease
Background: The American Heart Association's 2021 Scientific Statement on Psychological Health, Well‐Being, and the Mind–Heart–Body Connection affirms the critical role contributed by psychosocial factors in cardiovascular disease outcomes, yet the cited resource continues to lack the sex‐specific rigor necessary for equitable clinical guidance. Methods: We conducted a review of 206 research articles cited in the statement to assess whether studies reported participant sex, reported the percentage of women enrolled, tested for sex differences, and performed sex‐disaggregated analyses. Results: Although 71% of studies disclosed participant sex, only 29% examined results by sex, drew sex‐inclusive conclusions (27%), or performed appropriate subgroup analyses (25%). These practices varied significantly by study design: randomized controlled trials, the gold standard of clinical evidence and most relied upon for clinical practice guidelines, had the lowest rates of female‐majority (≥50%) enrollment, while cohort and cross‐sectional designs were more inclusive. In pooled meta‐analytic data comprising 899 studies, male‐only trials exceeded female‐only ones, and 16% failed to report sex. Temporal trends revealed no meaningful improvement in sex reporting from 1987 to 2021, despite decades of policy reforms intended to close these gaps. While slight gains in female enrollment and analytic rigor were observed, they remain insufficient to meet the needs of sex‐responsive research. Conclusions: Our findings reveal a critical disconnect between the clinical importance of psychosocial factors and the sex representation in the evidence used to guide practice. Deliberate reforms in study design and analytic expectations are needed to ensure that future guidelines rest on an equitable foundation.
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e046951
Open AccessSex‐Specific Gaps in Cardiovascular Psychosocial Research: An Analysis of Studies Cited in the American Heart Association's 2021 Statement on Psychological Health and Cardiovascular Disease
Background: The American Heart Association's 2021 Scientific Statement on Psychological Health, Well‐Being, and the Mind–Heart–Body Connection affirms the critical role contributed by psychosocial factors in cardiovascular disease outcomes, yet the cited resource continues to lack the sex‐specific rigor necessary for equitable clinical guidance. Methods: We conducted a review of 206 research articles cited in the statement to assess whether studies reported participant sex, reported the percentage of women enrolled, tested for sex differences, and performed sex‐disaggregated analyses. Results: Although 71% of studies disclosed participant sex, only 29% examined results by sex, drew sex‐inclusive conclusions (27%), or performed appropriate subgroup analyses (25%). These practices varied significantly by study design: randomized controlled trials, the gold standard of clinical evidence and most relied upon for clinical practice guidelines, had the lowest rates of female‐majority (≥50%) enrollment, while cohort and cross‐sectional designs were more inclusive. In pooled meta‐analytic data comprising 899 studies, male‐only trials exceeded female‐only ones, and 16% failed to report sex. Temporal trends revealed no meaningful improvement in sex reporting from 1987 to 2021, despite decades of policy reforms intended to close these gaps. While slight gains in female enrollment and analytic rigor were observed, they remain insufficient to meet the needs of sex‐responsive research. Conclusions: Our findings reveal a critical disconnect between the clinical importance of psychosocial factors and the sex representation in the evidence used to guide practice. Deliberate reforms in study design and analytic expectations are needed to ensure that future guidelines rest on an equitable foundation.
- Open Access
- 1 September 2026
- Published by Elsevier in Resuscitation Plus
- Vol. 31
The implementation of diverse skin-toned female manikins in hospital provider basic life support training
- 1 September 2026
- Published by Elsevier in Resuscitation Plus
- Vol. 31
Open AccessThe implementation of diverse skin-toned female manikins in hospital provider basic life support training
- Open Access
- 29 June 2025
- Published by Wiley in Nursing Inquiry
- Vol. 32 (3) , e70045
There Is Never Really Just a Simple Choice: Nurse Advocacy for Gender‐Transformative Cardiovascular Disease Prevention
Cardiovascular disease remains the leading cause of mortality for women globally and presents a considerable health burden despite decades of awareness campaigns. Messaging in these campaigns includes a significant focus on individual lifestyle behaviour modification for the prevention of cardiovascular disease, with health promotion campaigns and clinical organizations stating that 80%–90% of cardiovascular disease is preventable. Public messaging campaigns on prevention strategies have historically lacked differentiation for gender. As a result, they can overlook the complex factors that may hinder women from achieving the suggested lifestyle modifications, including the long‐promoted trio of diet, exercise and tobacco. The non‐coherence between the logics guiding cardiovascular disease prevention messaging and the competing logics of everyday life for women deserves attention. In this paper, we explore the assumptions evident in common cardiovascular disease prevention narratives and propose that nurses are well‐positioned to advocate for gender‐transformative health promotion.
- 29 June 2025
- Published by Wiley in Nursing Inquiry
- Vol. 32 (3) , e70045
Open AccessThere Is Never Really Just a Simple Choice: Nurse Advocacy for Gender‐Transformative Cardiovascular Disease Prevention
Cardiovascular disease remains the leading cause of mortality for women globally and presents a considerable health burden despite decades of awareness campaigns. Messaging in these campaigns includes a significant focus on individual lifestyle behaviour modification for the prevention of cardiovascular disease, with health promotion campaigns and clinical organizations stating that 80%–90% of cardiovascular disease is preventable. Public messaging campaigns on prevention strategies have historically lacked differentiation for gender. As a result, they can overlook the complex factors that may hinder women from achieving the suggested lifestyle modifications, including the long‐promoted trio of diet, exercise and tobacco. The non‐coherence between the logics guiding cardiovascular disease prevention messaging and the competing logics of everyday life for women deserves attention. In this paper, we explore the assumptions evident in common cardiovascular disease prevention narratives and propose that nurses are well‐positioned to advocate for gender‐transformative health promotion.
- Open Access
- 1 January 2025
- Published by SAGE Publications in Women's Health Reports
- Vol. 6 (1) , 925-935
Effectiveness of Interventions to Improve Cardiovascular Perturbations in Women with Exercise-Associated Amenorrhea: A Systematic Review
Objectives: Women with exercise-associated amenorrhea demonstrate cardiovascular perturbations such as endothelial dysfunction and altered lipid profiles. The objective of this systematic review was to assess the effectiveness of pharmacological/nutraceutical and non-pharmacological interventions for improving these cardiovascular perturbations. Design, Data Sources, and Eligibility Criteria: A literature search was performed in October 2023 and updated in July 2024 of CINAHL (EBSCOhost), Cochrane Library, Embase (Ovid), MEDLINE (Ovid), SPORTDiscus (EBSCOhost), and Scopus from inception to present with no date or language limitations and four sources of gray literature. Experimental and quasi-experimental pre–post studies of women with exercise-associated amenorrhea, using pharmacological/nutraceutical or non-pharmacological intervention, were included. Results and Summary: Three studies from three countries were included. Interventions included 9 months of low-dose oral contraceptives and 4 weeks of folic acid (10 mg/day). Both interventions improved endothelial function in women experiencing exercise-associated amenorrhea, from 1.42% to 4.88% and 3.0% to 7.7%, respectively. The impact of oral contraceptives on lipids was conflicting, and increases were seen in select inflammatory markers, including high-sensitivity C-reactive protein and tumor necrosis factor. Conclusion: Oral contraceptives or folic acid may improve the endothelial dysfunction associated with exercise-associated amenorrhea. As cardiovascular disease remains a global cause of mortality for women, further investigation into the long-term cardiovascular consequences of impaired vascular and lipid profiles of exercise-associated amenorrhea is warranted.
- 1 January 2025
- Published by SAGE Publications in Women's Health Reports
- Vol. 6 (1) , 925-935
Open AccessEffectiveness of Interventions to Improve Cardiovascular Perturbations in Women with Exercise-Associated Amenorrhea: A Systematic Review
Objectives: Women with exercise-associated amenorrhea demonstrate cardiovascular perturbations such as endothelial dysfunction and altered lipid profiles. The objective of this systematic review was to assess the effectiveness of pharmacological/nutraceutical and non-pharmacological interventions for improving these cardiovascular perturbations. Design, Data Sources, and Eligibility Criteria: A literature search was performed in October 2023 and updated in July 2024 of CINAHL (EBSCOhost), Cochrane Library, Embase (Ovid), MEDLINE (Ovid), SPORTDiscus (EBSCOhost), and Scopus from inception to present with no date or language limitations and four sources of gray literature. Experimental and quasi-experimental pre–post studies of women with exercise-associated amenorrhea, using pharmacological/nutraceutical or non-pharmacological intervention, were included. Results and Summary: Three studies from three countries were included. Interventions included 9 months of low-dose oral contraceptives and 4 weeks of folic acid (10 mg/day). Both interventions improved endothelial function in women experiencing exercise-associated amenorrhea, from 1.42% to 4.88% and 3.0% to 7.7%, respectively. The impact of oral contraceptives on lipids was conflicting, and increases were seen in select inflammatory markers, including high-sensitivity C-reactive protein and tumor necrosis factor. Conclusion: Oral contraceptives or folic acid may improve the endothelial dysfunction associated with exercise-associated amenorrhea. As cardiovascular disease remains a global cause of mortality for women, further investigation into the long-term cardiovascular consequences of impaired vascular and lipid profiles of exercise-associated amenorrhea is warranted.
- Open Access
- 25 July 2024
- Published by Public Library of Science (PLoS) in PLOS Mental Health
- Vol. 1 (2) , e0000048
Sex and gender reporting in RCTs of internet and mobile-based interventions for depression and anxiety in chronic conditions: A secondary analysis of a systematic review
Mind-body internet- and mobile-based intervention (IMIs) are gaining traction as scalable and effective strategies to manage mental health symptoms experienced by people living with chronic physical conditions. Sex and gender have implications for mind-body IMI participation, adherence, and efficacy. The objective of this secondary analysis was to assess the extent and nature of reporting of sex and/or gender in randomized controlled trials retrieved by a primary systematic review of mind-body IMIs assessing depression and anxiety symptoms among adults living with chronic physical conditions. The collected information included whether sex and gender-based analyses were carried out and explored the role of sex and gender on mental health outcomes, attrition, and recruitment rates. The protocol was registered with PROSPERO. A comprehensive search of six electronic databases was completed from database inception to March 2023. Sex and gender terms were summarized according to a standardized, three-point criteria: (1) non-binary use (i.e., > 2 categories used for both sex and gender definitions) (2) use of appropriate categories (i.e., sex = male/female/intersex, gender = man/woman/gender-diverse) and (3) non-interchangeable use of sex or gender terms throughout the citation. The use of sex and gender terms was deemed correct if all three criteria were met. The role of sex and gender on mental health outcomes, attrition and recruitment data were extracted where available. In the 56 included studies, 7691 participants were evaluated with a mean age of 43 years and 4780 (62%) were described as females/women. Two (4%) studies defined sex or gender using non-binary categorization. Twenty-eight (50%) studies used appropriate categories to define sex or gender. Twenty-five (45%) studies used sex and gender terms non-interchangeably. No studies met all three sex/gender criteria. Only one study provided stratified mental health scores by sex and/or gender within the publication. Eleven (20%) studies reported sex or gender imbalance as being a potential reason for outcome differences, with 3 studies conducting an adjusted statistical analysis investigating sex/gender as a moderator. Findings highlight low uptake of sex and gender considerations in the context of mind-body IMIs. Results underscore the need to incorporate guideline-based sex and gender terms and concepts, from data collection and analysis to reporting of evidence to inform mind-body IMI development and guide future research. Stratified sex and/or gender analyses are encouraged in future studies to assess intervention outcome differences.
- 25 July 2024
- Published by Public Library of Science (PLoS) in PLOS Mental Health
- Vol. 1 (2) , e0000048
Open AccessSex and gender reporting in RCTs of internet and mobile-based interventions for depression and anxiety in chronic conditions: A secondary analysis of a systematic review
Mind-body internet- and mobile-based intervention (IMIs) are gaining traction as scalable and effective strategies to manage mental health symptoms experienced by people living with chronic physical conditions. Sex and gender have implications for mind-body IMI participation, adherence, and efficacy. The objective of this secondary analysis was to assess the extent and nature of reporting of sex and/or gender in randomized controlled trials retrieved by a primary systematic review of mind-body IMIs assessing depression and anxiety symptoms among adults living with chronic physical conditions. The collected information included whether sex and gender-based analyses were carried out and explored the role of sex and gender on mental health outcomes, attrition, and recruitment rates. The protocol was registered with PROSPERO. A comprehensive search of six electronic databases was completed from database inception to March 2023. Sex and gender terms were summarized according to a standardized, three-point criteria: (1) non-binary use (i.e., > 2 categories used for both sex and gender definitions) (2) use of appropriate categories (i.e., sex = male/female/intersex, gender = man/woman/gender-diverse) and (3) non-interchangeable use of sex or gender terms throughout the citation. The use of sex and gender terms was deemed correct if all three criteria were met. The role of sex and gender on mental health outcomes, attrition and recruitment data were extracted where available. In the 56 included studies, 7691 participants were evaluated with a mean age of 43 years and 4780 (62%) were described as females/women. Two (4%) studies defined sex or gender using non-binary categorization. Twenty-eight (50%) studies used appropriate categories to define sex or gender. Twenty-five (45%) studies used sex and gender terms non-interchangeably. No studies met all three sex/gender criteria. Only one study provided stratified mental health scores by sex and/or gender within the publication. Eleven (20%) studies reported sex or gender imbalance as being a potential reason for outcome differences, with 3 studies conducting an adjusted statistical analysis investigating sex/gender as a moderator. Findings highlight low uptake of sex and gender considerations in the context of mind-body IMIs. Results underscore the need to incorporate guideline-based sex and gender terms and concepts, from data collection and analysis to reporting of evidence to inform mind-body IMI development and guide future research. Stratified sex and/or gender analyses are encouraged in future studies to assess intervention outcome differences.
- Open Access
- 19 March 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (6) , e033154
Impact of Secondary Amenorrhea on Cardiovascular Disease Risk in Physically Active Women: A Systematic Review and Meta‐Analysis
Background: Exercise‐associated secondary amenorrhea results in estrogen deficiency, which may lead to dysfunction in estrogen's normal cardioprotective pathways. Estrogen may be essential in a woman's endothelial adaptations to exercise. The objective of this review was to assess the association between secondary amenorrhea in physically active women and cardiovascular disease (CVD) risk. Methods and Results: A literature search was performed in January 2023 and updated in August 2023 of the Cumulative Index to Nursing and Allied Health Literature (EBSCOhost), Cochrane Library, Embase (Ovid), MEDLINE (Ovid), SPORTDiscus (EBSCOhost), and Scopus from inception to present with no date or language limitations. Citation chaining was done to screen for additional studies. Eight sources were searched for gray literature. Studies that compared physically active women with amenorrhea to physically active women with eumenorrhea aged 18 to 35 years with evidence of CVD, alterations to cardiovascular physiology, or CVD risks were included. Eighteen observational studies from 3 countries were included. Overall, the quality of evidence was good. A meta‐analysis was performed. Physically active women with secondary amenorrhea had significantly lower estradiol, flow‐mediated dilation, resting heart rate, systolic blood pressure, and diastolic blood pressure and higher total cholesterol, triglycerides, high‐density lipoprotein, and low‐density lipoprotein cholesterol. Conclusions: Estrogen deficiency resulting from exercise‐associated secondary amenorrhea in physically active women may impact cardiovascular physiology and certain CVD risk factors. The research in this area is observational; therefore, findings should be interpreted cautiously. However, as exercise‐associated secondary amenorrhea is reversible and the primary prevention of CVD is important for public health, it may be important to treat secondary amenorrhea and restore estrogen levels.
- 19 March 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (6) , e033154
Open AccessImpact of Secondary Amenorrhea on Cardiovascular Disease Risk in Physically Active Women: A Systematic Review and Meta‐Analysis
Background: Exercise‐associated secondary amenorrhea results in estrogen deficiency, which may lead to dysfunction in estrogen's normal cardioprotective pathways. Estrogen may be essential in a woman's endothelial adaptations to exercise. The objective of this review was to assess the association between secondary amenorrhea in physically active women and cardiovascular disease (CVD) risk. Methods and Results: A literature search was performed in January 2023 and updated in August 2023 of the Cumulative Index to Nursing and Allied Health Literature (EBSCOhost), Cochrane Library, Embase (Ovid), MEDLINE (Ovid), SPORTDiscus (EBSCOhost), and Scopus from inception to present with no date or language limitations. Citation chaining was done to screen for additional studies. Eight sources were searched for gray literature. Studies that compared physically active women with amenorrhea to physically active women with eumenorrhea aged 18 to 35 years with evidence of CVD, alterations to cardiovascular physiology, or CVD risks were included. Eighteen observational studies from 3 countries were included. Overall, the quality of evidence was good. A meta‐analysis was performed. Physically active women with secondary amenorrhea had significantly lower estradiol, flow‐mediated dilation, resting heart rate, systolic blood pressure, and diastolic blood pressure and higher total cholesterol, triglycerides, high‐density lipoprotein, and low‐density lipoprotein cholesterol. Conclusions: Estrogen deficiency resulting from exercise‐associated secondary amenorrhea in physically active women may impact cardiovascular physiology and certain CVD risk factors. The research in this area is observational; therefore, findings should be interpreted cautiously. However, as exercise‐associated secondary amenorrhea is reversible and the primary prevention of CVD is important for public health, it may be important to treat secondary amenorrhea and restore estrogen levels.
- 19 November 2023
- Published by Springer Nature
- p. 21-33
The Effects of Sex Steroid Hormones on Cardiovascular Physiology in Females
- 19 November 2023
- Published by Springer Nature
- p. 21-33
The Effects of Sex Steroid Hormones on Cardiovascular Physiology in Females
- 2 August 2023
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 22 (2) , 343-350
Impact of secondary amenorrhea on cardiovascular disease risk in physically active women: a systematic review protocol
Objective: The objective of this review is to assess the association between secondary amenorrhea in physically active women and cardiovascular disease risk. Introduction: It is well established that a woman’s risk of cardiovascular disease greatly increases after menopause. The sharp decline in estrogen is seen as a causal factor. Exercise-induced secondary amenorrhea results in estrogen deficiency, which may lead to dysfunction in estrogen’s cardioprotective pathways. Further, estrogen may be essential in a woman’s endothelial adaptations to exercise. The impact of secondary amenorrhea on cardiovascular disease risk in premenopausal women is not well established. Inclusion criteria: This review will consider studies that include physically active women experiencing amenorrhea in any country. Only studies that present evidence of cardiovascular disease, alterations to cardiovascular physiology, or data on cardiovascular risk factors (eg, lipid profile changes) will be considered. The review will consider experimental or observational epidemiological study designs. Methods: Searches will be conducted in CINAHL (EBSCOhost), Cochrane Library, Embase (Ovid), MEDLINE (Ovid), SPORTDiscus (EBSCOhost), and Scopus from inception to present with no date or language limitations. Two independent reviewers will screen titles, abstracts, and full texts, appraise methodological quality, and extract data from studies. Where possible, studies will be pooled in a statistical meta-analysis in addition to subgroup analyses. Where pooling is not possible, the findings will be presented in narrative format. Certainty of the evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Systematic review registration number: PROSPERO CRD42023360781
- 2 August 2023
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 22 (2) , 343-350
Impact of secondary amenorrhea on cardiovascular disease risk in physically active women: a systematic review protocol
Objective: The objective of this review is to assess the association between secondary amenorrhea in physically active women and cardiovascular disease risk. Introduction: It is well established that a woman’s risk of cardiovascular disease greatly increases after menopause. The sharp decline in estrogen is seen as a causal factor. Exercise-induced secondary amenorrhea results in estrogen deficiency, which may lead to dysfunction in estrogen’s cardioprotective pathways. Further, estrogen may be essential in a woman’s endothelial adaptations to exercise. The impact of secondary amenorrhea on cardiovascular disease risk in premenopausal women is not well established. Inclusion criteria: This review will consider studies that include physically active women experiencing amenorrhea in any country. Only studies that present evidence of cardiovascular disease, alterations to cardiovascular physiology, or data on cardiovascular risk factors (eg, lipid profile changes) will be considered. The review will consider experimental or observational epidemiological study designs. Methods: Searches will be conducted in CINAHL (EBSCOhost), Cochrane Library, Embase (Ovid), MEDLINE (Ovid), SPORTDiscus (EBSCOhost), and Scopus from inception to present with no date or language limitations. Two independent reviewers will screen titles, abstracts, and full texts, appraise methodological quality, and extract data from studies. Where possible, studies will be pooled in a statistical meta-analysis in addition to subgroup analyses. Where pooling is not possible, the findings will be presented in narrative format. Certainty of the evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Systematic review registration number: PROSPERO CRD42023360781